# Dupilumab Impact on Skin Resident Memory T Cells

> **NCT03983460** · NA · UNKNOWN · sponsor: **Association pour la Recherche Clinique et Immunologique** · enrollment: 20 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Dupilumab
- **DRUG:** Optimized TCS treatment
- **PROCEDURE:** Biopsies
- **PROCEDURE:** Skin prick-test
- **PROCEDURE:** Blood sample collection

## Key facts

- **NCT ID:** NCT03983460
- **Lead sponsor:** Association pour la Recherche Clinique et Immunologique
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-09
- **Primary completion:** 2021-06
- **Final completion:** 2021-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03983460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03983460, "Dupilumab Impact on Skin Resident Memory T Cells". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03983460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*